End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
39.51
CNY
|
-4.80%
|
|
-8.27%
|
-20.46%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,992
|
5,291
|
5,285
|
6,870
|
5,465
|
-
|
-
|
Enterprise Value (EV)
1 |
1,992
|
5,291
|
5,285
|
6,870
|
5,465
|
5,465
|
5,465
|
P/E ratio
|
39.8
x
|
65.9
x
|
43.4
x
|
78.8
x
|
27
x
|
18.4
x
|
16.3
x
|
Yield
|
-
|
-
|
0.46%
|
0.26%
|
0.73%
|
1.13%
|
1.29%
|
Capitalization / Revenue
|
-
|
-
|
14.4
x
|
18.2
x
|
8.05
x
|
5.78
x
|
4.88
x
|
EV / Revenue
|
-
|
-
|
14.4
x
|
18.2
x
|
8.05
x
|
5.78
x
|
4.88
x
|
EV / EBITDA
|
-
|
-
|
-
|
62.5
x
|
22.8
x
|
18.4
x
|
14.7
x
|
EV / FCF
|
-
|
-
|
225
x
|
-306
x
|
152
x
|
45.9
x
|
-
|
FCF Yield
|
-
|
-
|
0.44%
|
-0.33%
|
0.66%
|
2.18%
|
-
|
Price to Book
|
-
|
-
|
8.81
x
|
10.3
x
|
6.43
x
|
4.75
x
|
3.96
x
|
Nbr of stocks (in thousands)
|
138,320
|
138,320
|
138,320
|
138,320
|
138,320
|
-
|
-
|
Reference price
2 |
14.40
|
38.25
|
38.21
|
49.67
|
39.51
|
39.51
|
39.51
|
Announcement Date
|
2/7/21
|
3/28/22
|
3/9/23
|
4/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
367.1
|
378.2
|
679
|
944.9
|
1,121
|
EBITDA
1 |
-
|
-
|
-
|
109.9
|
240
|
297.1
|
372.1
|
EBIT
1 |
-
|
-
|
136.2
|
99.93
|
227.9
|
332.2
|
377.4
|
Operating Margin
|
-
|
-
|
37.1%
|
26.42%
|
33.56%
|
35.16%
|
33.67%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
136
|
99.48
|
227.7
|
332.1
|
377.2
|
Net income
1 |
50.08
|
80.02
|
121.8
|
87.75
|
202.7
|
297.1
|
335.9
|
Net margin
|
-
|
-
|
33.17%
|
23.2%
|
29.85%
|
31.44%
|
29.96%
|
EPS
2 |
0.3621
|
0.5800
|
0.8800
|
0.6300
|
1.465
|
2.147
|
2.430
|
Free Cash Flow
1 |
-
|
-
|
23.48
|
-22.44
|
36
|
119
|
-
|
FCF margin
|
-
|
-
|
6.4%
|
-5.93%
|
5.3%
|
12.59%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
15%
|
40.05%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
19.28%
|
-
|
17.76%
|
40.06%
|
-
|
Dividend per Share
2 |
-
|
-
|
0.1770
|
0.1280
|
0.2900
|
0.4450
|
0.5100
|
Announcement Date
|
2/7/21
|
3/28/22
|
3/9/23
|
4/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
23.5
|
-22.4
|
36
|
119
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
22.2%
|
14%
|
23.8%
|
25.8%
|
23.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
19.7%
|
-
|
20.7%
|
21.8%
|
22.4%
|
Assets
1 |
-
|
-
|
618.8
|
-
|
979.2
|
1,363
|
1,499
|
Book Value Per Share
2 |
-
|
-
|
4.340
|
4.800
|
6.140
|
8.320
|
9.990
|
Cash Flow per Share
2 |
-
|
-
|
0.2300
|
0.0300
|
0.9700
|
0.9600
|
1.100
|
Capex
1 |
-
|
-
|
7.9
|
26.6
|
19.5
|
19.3
|
17.3
|
Capex / Sales
|
-
|
-
|
2.15%
|
7.02%
|
2.87%
|
2.04%
|
1.54%
|
Announcement Date
|
2/7/21
|
3/28/22
|
3/9/23
|
4/15/24
|
-
|
-
|
-
|
Last Close Price
39.51
CNY Average target price
47.04
CNY Spread / Average Target +19.06% Consensus |
1st Jan change
|
Capi.
|
---|
| -20.46% | 756M | | +11.31% | 34.72B | | +26.86% | 8.77B | | +11.21% | 7.98B | | +27.21% | 5.77B | | +41.80% | 4.22B | | -4.38% | 4.13B | | +14.17% | 3.72B | | +12.77% | 3.67B | | -10.28% | 2.71B |
Testing & Measuring Equipment
|